Discover 521 paid clinical trials in Calgary, . Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Calgary runs one of the busiest research programs in western Canada, with hundreds of studies recruiting at any given time.The Arthur J.E. Child Comprehensive Cancer Centre opened in Calgary in October 2024, making cancer research the city's fastest-growing trial area. Roughly a third of Calgary's recruiting studies are in oncology, and the rest cluster around heart failure, kidney disease, and metabolic conditions, much of it run through the University of Calgary. The city is also unusual for the volume of paediatric research at Alberta Children's Hospital, so families often find studies here that are not available elsewhere in the province.
Filter
2
Filter results
Results: 521
Active & Responsive
Finding Alternatives to Standard Treatment for Attention-Deficit Hyperactivity Disorder
for
Attention-Deficit/Hyperactivity Disorder (ADHD)
Location: Calgary
Sponsor: University of Calgary
Sex: All
Age: 9 - 15
Code: NCT04532190
Recruiting
Active & Responsive
Brain STimulation for ANxiety and Depression in Youth
for
Anxiety Disorders, Depression
Location: Calgary
Sponsor: University of Calgary
Sex: All
Age: 6 - 18
Code: NCT06892847
Recruiting
Active & Responsive
A Phase IIb Dose-ranging Study to Assess the Efficacy and Safety of GIA632 in Participants With Non-segmental Vitiligo
for
Non-segmental Vitiligo
Location: Calgary, Portland OR, Winnipeg, Las Vegas NV, Omaha NE,
Sponsor: Novartis Pharmaceuticals
Sex: All
Age: 18 - 70+
Code: NCT07431177
Phase 2, Recruiting
Active & Responsive
A Study of JNT-517 in Participants With Phenylketonuria (PKU)
for
Phenylketonuria
Location: Calgary, Portland OR, Salt Lake City UT, Los Angeles CA,
Sponsor: Otsuka Pharmaceutical Development & Commercialization, Inc.
Sex: All
Age: 4+
Code: NCT06971731
Phase 3, Recruiting
Active & Responsive
A Study to Evaluate the Safety and Efficacy of Oral Nizubaglustat (AZ-3102) in Late-infantile and Juvenile Forms of Niemann-Pick Type C Disease (NPC)
for
Niemann-Pick Type C Disease
Location: Calgary, Oakland CA, Minneapolis MN, Rochester MN,
Sponsor: Azafaros B.V.
Sex: All
Age: 4+
Code: NCT07082725
Phase 3, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Active & Responsive
A Gaucher Disease Gene Therapy Trial With FLT201
for
Gaucher Disease Type 1
Location: Calgary, Aurora CO, San Francisco CA, Minneapolis MN,
Sponsor: Spur Therapeutics
Sex: All
Age: 18+
Code: NCT07223944
Phase 3, Recruiting
Active & Responsive
A Long-term Safety and Efficacy Study Evaluating APG777 in Atopic Dermatitis
for
Atopic Dermatitis
Location: Calgary, Edmonton, Vancouver, Mill Creek WA,
Sponsor: Apogee Therapeutics, Inc.
Sex: All
Age: 18+
Code: NCT07003425
Phase 2, Recruiting
Active & Responsive
A Study to Evaluate Effect of AZD6234 in Adult Participants With Obesity or Overweight With Weight-related Comorbidity Without Type 2 Diabetes Mellitus
for
Obesity or Overweight
Location: Calgary, New Westminster, Victoria, Fargo ND, Ames IA,
Sponsor: AstraZeneca
Sex: All
Age: 18+
Code: NCT07784725
Phase 3, Recruiting
Active & Responsive
A Study to Evaluate Effect of AZD6234 as an Adjunct to Incretin-based Therapies in Adult Participants With Obesity or Overweight With Weight-related Comorbidity With or Without Type 2 Diabetes Mellitus
for
Obesity or Overweight, Weight-Related Comorbidity,
Location: Calgary, Surrey, Vancouver, Fargo ND, Lincoln CA,
Ivosidenib in Participants With Locally Advanced or Metastatic Conventional Chondrosarcoma Untreated or Previously Treated With 1 or 2 Systemic Treatment Regimens
for
Locally Advanced or Metastatic Conventional Chondrosarcoma With an IDH1 Mutation, Untreated or Previously Treated With 1 Systemic Treatment Regimen,